JP2020531587A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531587A5
JP2020531587A5 JP2020532849A JP2020532849A JP2020531587A5 JP 2020531587 A5 JP2020531587 A5 JP 2020531587A5 JP 2020532849 A JP2020532849 A JP 2020532849A JP 2020532849 A JP2020532849 A JP 2020532849A JP 2020531587 A5 JP2020531587 A5 JP 2020531587A5
Authority
JP
Japan
Prior art keywords
composition
type
collagen
vitamin
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020532849A
Other languages
English (en)
Japanese (ja)
Other versions
JP7748802B2 (ja
JP2020531587A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/047267 external-priority patent/WO2019040459A2/en
Publication of JP2020531587A publication Critical patent/JP2020531587A/ja
Publication of JP2020531587A5 publication Critical patent/JP2020531587A5/ja
Priority to JP2023095466A priority Critical patent/JP2023113905A/ja
Application granted granted Critical
Publication of JP7748802B2 publication Critical patent/JP7748802B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020532849A 2017-08-21 2018-08-21 組成物およびそれから作られた栄養サプリメント Active JP7748802B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023095466A JP2023113905A (ja) 2017-08-21 2023-06-09 組成物およびそれから作られた栄養サプリメント

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762547951P 2017-08-21 2017-08-21
US62/547,951 2017-08-21
PCT/US2018/047267 WO2019040459A2 (en) 2017-08-21 2018-08-21 COMPOSITION AND NUTRITIONAL SUPPLEMENT PRODUCED THEREFROM

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023095466A Division JP2023113905A (ja) 2017-08-21 2023-06-09 組成物およびそれから作られた栄養サプリメント

Publications (3)

Publication Number Publication Date
JP2020531587A JP2020531587A (ja) 2020-11-05
JP2020531587A5 true JP2020531587A5 (enExample) 2021-09-30
JP7748802B2 JP7748802B2 (ja) 2025-10-03

Family

ID=63668005

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020532849A Active JP7748802B2 (ja) 2017-08-21 2018-08-21 組成物およびそれから作られた栄養サプリメント
JP2023095466A Pending JP2023113905A (ja) 2017-08-21 2023-06-09 組成物およびそれから作られた栄養サプリメント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023095466A Pending JP2023113905A (ja) 2017-08-21 2023-06-09 組成物およびそれから作られた栄養サプリメント

Country Status (6)

Country Link
US (1) US20190054152A1 (enExample)
EP (1) EP3655018B1 (enExample)
JP (2) JP7748802B2 (enExample)
CN (1) CN111163797A (enExample)
BR (1) BR112020003598A8 (enExample)
WO (1) WO2019040459A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022096826A (ja) * 2020-12-18 2022-06-30 株式会社ノエビア 経口用組成物
EP4378470A4 (en) * 2021-05-30 2025-08-13 Source Of Life Biotechnology Company Ltd NATURAL TOPICAL SKIN EXTRACT FOR THE TREATMENT OF JOINT DEGENERATION AND OSTEOPOROSIS AND METHOD
CN118216673A (zh) * 2024-03-15 2024-06-21 内蒙古草原鑫河生物科技有限公司 一种维生素a补充剂微胶囊及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
ES2299687T3 (es) * 2002-01-30 2008-06-01 Dsm Ip Assets B.V. Luteina/zeaxantina para la proteccion contra el encandilamiento.
WO2007076416A2 (en) * 2005-12-20 2007-07-05 Alcon Research, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US9011930B2 (en) 2006-05-01 2015-04-21 Zycal Bioceuticals Healthcare Company, Inc. Nutritional supplement and use thereof
US8703174B2 (en) * 2006-09-15 2014-04-22 I Did It Inc Joint preserving nutritional vitamin, mineral and herbal pet supplement
IT1392084B1 (it) * 2008-12-12 2012-02-09 Marzullo Composizione immuno-nutrizionale
US9402857B2 (en) * 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
US20110218151A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
US20110217370A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising glucosamine sulfate, omega-3 polyunsaturated fatty acids or derivatives thereof, and undenatured type ii collagen
JP5779075B2 (ja) * 2011-11-02 2015-09-16 株式会社ファンケル 関節炎の予防剤
US20140287071A1 (en) 2013-01-17 2014-09-25 Lifevantage Corporation Veterinary supplements
US20160324146A1 (en) * 2013-05-15 2016-11-10 Eugene R. Moore Preservation of the biological activity of undenatured type II collagen
US20160192689A1 (en) * 2013-07-31 2016-07-07 Wikifoods, Inc. Encapsulated functional food compositions
KR101664290B1 (ko) * 2013-10-24 2016-10-11 인터헬쓰 뉴트라슈티칼즈 인코포레이티드 비관절염 포유동물의 운동으로 유발된 관절 통증을 감소시키는 방법
CN104223120A (zh) 2014-08-20 2014-12-24 青岛贝尔特生物科技有限公司 一种供半月板损伤患者食用含低分子硫酸软骨素的特殊膳食用食品配方
CN104489696A (zh) * 2014-12-10 2015-04-08 常州兆阳光能科技有限公司 健脑保健营养液
US10226513B2 (en) 2015-01-09 2019-03-12 Mark Terrell Smith Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration

Similar Documents

Publication Publication Date Title
Krinsky et al. Carotenoid actions and their relation to health and disease
Bernstein et al. Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease
Chapman Vitamin a: history, current uses, and controversies
JP2020531587A5 (enExample)
JP2020127400A (ja) 脂質含有組成物およびその使用方法
WO2005110375A8 (en) Nutritional supplement for treatment of ocular diseases
Hassan et al. Dietary supplements: Types, health benefits, industry and regulation
BR0208640A (pt) Suplemento nutricional para tratar degeneração macular
SG189855A1 (en) Optimized nutritional formulations, methods for selection of tailored diets therefrom, and methods of use thereof
US20090118229A1 (en) Carotenoid-containing compositions and methods
JP6132360B2 (ja) ジインドリルメタン及びレチノイドを含む皮膚症状を治療するための組成物
BR122019027418B1 (pt) embalagem de alimentação em tubo
BRPI0410859A (pt) concentrado de carotenóide purificado, composição de carotenóide purificada diluìda, composição adequada para administração oral, substáncia alimentìcia ou bebida adequada para consumo de mamìfero, e, creme, loção ou ungüento tópico
JP6657394B2 (ja) ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤
JP2018517787A5 (enExample)
BRPI0410267A (pt) composições contendo enzimas, produtos alimentares dietéticos e medicamentos produzidos das mesmas e sua utilização para fins medicinais
GR20200100479A (el) Συμπληρωμα διατροφης για την προληψη και/ή τη θεραπεια του πονου και/ή νευροπαθειων
JP2023113905A (ja) 組成物およびそれから作られた栄養サプリメント
Ulbricht et al. An evidence-based systematic review of vitamin A by the natural standard research collaboration
CA2970665A1 (en) Non-winterized, standardized marine source oil products and methods of making thereof
JP2014520556A5 (enExample)
EP3024450B1 (en) Compositions and methods using tiglic aldehyde
US11696593B2 (en) Astaxanthin nutritional compositions and uses
Saba et al. Nutraceuticals from Seafood: Role in Health and Disease Prevention
Desai et al. Nutritional deficiency disorders